BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Xenomics Inc. 

420 Lexington Avenue, Suite 1701

New York  New York  10170  U.S.A.
Phone: 212-729-9216 Fax: 212-297-0020


SEARCH JOBS




Industry
Suppliers






 Company News
Xenomics Inc. (XNOM)'s Preliminary Investigation Leads the Company to Believe Sequenom Inc. (SQNM) Willfully Manipulated its Down Syndrome Data in its Presentations 12/17/2009 10:41:20 AM    More...
Xenomics Inc. (XNOM) and its Subsidiary TrovaGene, Inc., Announce Italian Patent for NPM1 Testing for AML Patients 12/15/2009 11:51:14 AM    More...
Xenomics Inc. (XNOM) Files Suit Against Sequenom Inc. (SQNM) (JOBS) for Fraud 10/29/2009 6:19:04 AM    More...
Xenomics Inc. (XNOM) Appoints Bruce A. Huebner as Chief Executive Officer and Board Member 10/6/2009 6:39:45 AM    More...
Xenomics Inc. (XNOM) Presents New Diagnostics Platform: Detection of In Vivo Cell Death by Analysis of Cell-Free Tissue-Specific miRNA in Urine or Blood 3/23/2009 9:02:04 AM    More...
Xenomics Inc. (XNOM) Provides Update on NPM1 Testing for AML 2/24/2009 10:24:21 AM    More...
Editorial Article in the Clinical Chemistry Highlights Significant Progress in Optimization of the Non-Invasive Transrenal DNA Technology Reported by Xenomics Inc. (XNOM) 2/23/2009 10:03:12 AM    More...
Xenomics Inc. (XNOM) Offers New Gender Prediction Test to Expectant Mothers 2/17/2009 12:42:30 PM    More...
Xenomics Inc. (XNOM) Transrenal Technology Shows Significant Promise in Molecular Diagnostic Applications 2/4/2009 2:35:49 PM    More...
Xenomics Inc. (XNOM) Discusses HPV Screening Test Based on Transrenal DNA Technology at 52nd All India Congress of Obstetrics & Gynecology 1/6/2009 11:40:04 AM    More...
12345678